Literature DB >> 8906750

Serum and secretory IgA from HIV-infected individuals mediate antibody-dependent cellular cytotoxicity.

K P Black1, J E Cummins, S Jackson.   

Abstract

The potential function of IgA anti-HIV antibodies in mediation of antibody-dependent cellular cytotoxicity (ADCC) was investigated in this study. Serum IgA isolated from HIV-seropositive subjects in stage B3 or C3 and from healthy seronegative individuals was compared to IgG and whole serum for the ability to mediate ADCC. Peripheral blood mononuclear cells isolated from uninfected donors were used as effectors against CEM-NKr cells chronically infected with the HTLV-IIIB strain of HIV-1. Whole sera, isolated IgA, and IgG from both groups of seropositive individuals were capable of significant ADCC lysis against infected CEM-NKr cells compared to identical preparations from seronegative individuals. In comparing ADCC activity between the two seropositive groups, IgG mediated higher mean ADCC levels in the C3 group at the two highest concentrations of antibody assayed (P < 0.03), whereas IgA mediated the highest mean ADCC levels in the B3 group at all concentrations. Secretory IgA (S-IgA) isolated from colostrum of HIV-infected women was also examined for ADCC capabilities against infected CEM-NKr cells. Significant differences were observed between ADCC mediated by S-IgA from seropositive mothers compared to seronegative mothers (P < 0.04), but the amount of lysis detected was not as great as that seen with serum IgA. The presence of IgG, serum IgA, and secretory IgA antibodies capable of mediating ADCC may be critical in maintaining a functional immune response in all stages of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8906750     DOI: 10.1006/clin.1996.0175

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  11 in total

1.  Plasma and salivary IgA subclasses and IgM in HIV-1-infected individuals.

Authors:  Xueling Wu; Susan Jackson
Journal:  J Clin Immunol       Date:  2002-03       Impact factor: 8.317

2.  Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads.

Authors:  Pratip Nag; Jenney Kim; Vytautas Sapiega; Alan L Landay; James W Bremer; Jiri Mestecky; Patricia Reichelderfer; Andrea Kovacs; Jonathan Cohn; Barbara Weiser; Linda L Baum
Journal:  J Infect Dis       Date:  2004-10-28       Impact factor: 5.226

3.  Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques.

Authors:  Kara Jensen; Rafiq Nabi; Koen K A Van Rompay; Spencer Robichaux; Jeffrey D Lifson; Michael Piatak; William R Jacobs; Glenn Fennelly; Don Canfield; Katie R Mollan; Michael G Hudgens; Michelle H Larsen; Angela M Amedee; Pamela A Kozlowski; Kristina De Paris
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

4.  Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.

Authors:  Amy W Chung; Manu P Kumar; Kelly B Arnold; Wen Han Yu; Matthew K Schoen; Laura J Dunphy; Todd J Suscovich; Nicole Frahm; Caitlyn Linde; Alison E Mahan; Michelle Hoffner; Hendrik Streeck; Margaret E Ackerman; M Juliana McElrath; Hanneke Schuitemaker; Maria G Pau; Lindsey R Baden; Jerome H Kim; Nelson L Michael; Dan H Barouch; Douglas A Lauffenburger; Galit Alter
Journal:  Cell       Date:  2015-11-05       Impact factor: 41.582

Review 5.  The role of Fc receptors in HIV prevention and therapy.

Authors:  Austin W Boesch; Eric P Brown; Margaret E Ackerman
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

6.  IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.

Authors:  Maxence Duchemin; Marwa Khamassi; Lin Xu; Daniela Tudor; Morgane Bomsel
Journal:  Front Immunol       Date:  2018-03-29       Impact factor: 7.561

Review 7.  Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1.

Authors:  George K Lewis; Margaret E Ackerman; Gabriella Scarlatti; Christiane Moog; Marjorie Robert-Guroff; Stephen J Kent; Julie Overbaugh; R Keith Reeves; Guido Ferrari; Bargavi Thyagarajan
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

8.  Envelope-Specific IgG3 and IgG1 Responses Are Associated with Clearance of Acute Hepatitis C Virus Infection.

Authors:  Melanie R Walker; Auda A Eltahla; Michael M Mina; Hui Li; Andrew R Lloyd; Rowena A Bull
Journal:  Viruses       Date:  2020-01-08       Impact factor: 5.048

Review 9.  Are anti-HIV IgAs good guys or bad guys?

Authors:  Mingkui Zhou; Ruth M Ruprecht
Journal:  Retrovirology       Date:  2014-12-14       Impact factor: 4.602

10.  Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy.

Authors:  Rafiq Nabi; Zina Moldoveanu; Qing Wei; Elizabeth T Golub; Helen G Durkin; Ruth M Greenblatt; Betsy C Herold; Marek J Nowicki; Seble Kassaye; Michael W Cho; Abraham Pinter; Alan L Landay; Jiri Mestecky; Pamela A Kozlowski
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.